Dr. Reddy's Laboratories (RDY) was downgraded by The Goldman Sachs Group, Inc. from "neutral" to "sell".
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL [Yahoo! Finance]
Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments [Yahoo! Finance]
Ozempic copies for $14 as the generic GLP-1 era starts in India [Los Angeles Times (CA)]
India's Zydus, Lupin sign deal to co-market Semaglutide injections [Yahoo! Finance]